Trial intelligence / Profile preview

SUNSHINE: Vitamin D3 in metastatic colorectal cancer

NCT01516216Phase 2Completed

Sponsor
Dana-Farber Cancer Institute
Start
Apr 2012
Primary completion
Nov 2019
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 2 trial of cholecalciferol in colorectal cancer (metastatic) (mCRC), sponsored by Dana-Farber Cancer Institute. Started Apr 2012; status: completed.

02

Drugs

cholecalciferol
03

Conditions

colorectal cancer (metastatic) (mCRC)

Beyond the preview

Go deeper on NCT01516216.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01516216.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call